Mark W Schwartz 

Biotechnology Executive Dr. Mark W. Schwartz

A 25-year veteran of the biotechnology and life sciences industry, Mark W. Schwartz, PhD, has extensive experience in strategic planning, business development, and clinical and product development. A faculty member of San Jose State University since 2010, he serves as a board member for the school’s biotechnology program and teaches an entrepreneurship class focused on the funding and operation of a biotechnology start-up. Mark W. Schwartz concurrently serves as a director of the San Diego-based biopharmaceutical company Targazyme, Inc. 

Previously, Dr. Schwartz was the president and CEO of Bayhill Therapeutics, Inc., in which role he raised more than $100 million in equity and nondilutive funding for a gene treatment of autoimmune diseases. He has also held key leadership positions with firms such as Calyx Therapeutics, Inc., and Trega BioSciences, Inc. Mark W. Schwartz holds a bachelor of arts in chemistry from Grinnell College, where he worked as a chemistry tutor and was captain of the soccer team. He later earned a PhD in chemistry and biochemistry from Arizona State University. He has served on the boards of the Biotechnology Industry Association and its Emerging Companies Section Governing Board.

• Mark W Schwartz - AngelList
  

Discovery Bay, CA , US